Real-World Experience of Pidotimod in Mexican Pediatric Patients
Abstract
Introduction: Pidotimod is an immunostimulant molecule widely used to treat respiratory tract infections (RTIs) in children. It may also be useful for the treatment of allergic respiratory diseases. This real-world study evaluated the incidence of recurrent RTI after treatment with pidotimod in children with acute RTI or allergic disease in Mexico. Methods: This observational, cross-sectional, retrospective, two-center study included medical records of children with active RTI or risk of recurrent RTI who were prescribed pidotimod for acute/subacute or chronic respiratory disease in two private clinics in Mexico City. Results: Fifty children were included, (n=27, 54%) were girls, (n=39, 78%) were between 2 and 11 years of age and (n=10, 20%) were less than 2 years old, with a duration of follow-up that ranged between 11 and 384 days. The majority (n=36, 72%) received Pidotimod for both acute illness and prophylactic continuation; four children received Pidotimod only prophylactically. Forty children (80%) were prescribed Pidotimod for recurrent infection. The number of respiratory episodes decreased from 50 (100%) to 2 (4%), demonstrating an efficacy of 96%. Of the total patients treated with Pidotimod, 96% did not experience another infection during the follow-up period. No adverse events of Pidotimod were reported and almost all (n = 49, 98%) of the children found the taste of Pidotimod acceptable. Conclusions: Pidotimod demonstrated 96% efficacy in recurrent respiratory…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 49 participants or records.
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.